MedTrace Logo

China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

NCT05498974 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2026-04-28

No results posted yet for this study

Summary

The aim of the China Diabetes Type 1 Study (CD1S) is to conduct a nationwide type 1 diabetes (T1D) registry study in patients with T1D and in pediatric adolescent patients with diabetes who had an age of onset \<= 20 years.

CD1S compromises a retrospective study enrolling inpatients hospitalized from Jan 1st, 2016 to Dec 31, 2021, and a prospective study beginning from the year 2022.

Conditions

Interventions

OTHER

Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center

Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center

Sponsors & Collaborators

  • Second Xiangya Hospital of Central South University

    lead OTHER

Principal Investigators

  • Zhiguang Zhou, MD, PhD · The Second Xiangya Hospital, Central South University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2035-12-31
Completion
2035-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05498974 on ClinicalTrials.gov